Alkermes
ALKS
#2795
Rank
C$8.08 B
Marketcap
C$48.51
Share price
-0.60%
Change (1 day)
5.51%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : C$0.92 Billion

According to Alkermes's latest financial reports the company's total liabilities are C$0.92 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$0.91 B7.89%
2024-12-31C$0.84 B-31.55%
2023-12-31C$1.23 B-0.84%
2022-12-31C$1.24 B7.45%
2021-12-31C$1.16 B3.25%
2020-12-31C$1.12 B19.7%
2019-12-31C$0.94 B5.59%
2018-12-31C$0.89 B19.16%
2017-12-31C$0.74 B7.58%
2016-12-31C$0.69 B-7.51%
2015-12-31C$0.75 B23.94%
2014-12-31C$0.60 B
2013-03-31C$0.52 B-9.27%
2012-03-31C$0.58 B890.72%
2011-03-31C$58.59 M-43.57%
2010-03-31C$0.10 B-37.27%
2009-03-31C$0.16 B-53.5%
2008-03-31C$0.35 B-15.77%
2007-03-31C$0.42 B-19.07%
2006-03-31C$0.52 B28.59%
2005-03-31C$0.40 B60.08%
2004-03-31C$0.25 B-33.74%
2003-03-31C$0.38 B-4.24%
2002-03-31C$0.39 B4.34%
2001-03-31C$0.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$163.83 B 17,522.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$89.66 B 9,545.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$169.01 B 18,079.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$90.11 B 9,593.26%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$99.59 B 10,613.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$90.99 B 9,688.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
C$0.37 B-59.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$45.71 B 4,817.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel